0.0350
+0.0050
+(16.67%)
At close: January 10 at 9:30:00 AM EST
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
494.7840
827.4070
334.1770
1,390.6840
--
Operating Expense
1,557.1630
2,990.1970
8,109.9920
25,006.1300
14,372.2290
Operating Income
-1,062.3790
-2,162.7900
-7,775.8150
-23,615.4460
-14,372.2290
Net Non Operating Interest Income Expense
-2,576.7950
-1,614.1930
-1,066.2010
-1,521.2110
47.1170
Other Income Expense
71.1780
65.6560
-364.6060
56.8170
--
Pretax Income
-3,567.9960
-3,711.3270
-9,206.6220
-25,079.8400
-14,325.1120
Tax Provision
16.2050
69.5830
36.3920
38.4590
--
Net Income Common Stockholders
-3,584.2010
-3,780.9100
-9,243.0140
-25,118.2990
-14,325.1120
Diluted NI Available to Com Stockholders
-3,584.2010
-3,780.9100
-9,243.0140
-25,118.2990
-14,325.1120
Basic EPS
-0.03
-0.03
-0.08
-0.38
-0.24
Diluted EPS
-0.03
-0.03
-0.08
-0.38
-0.24
Basic Average Shares
121,266.1200
121,266.1200
113,731.8730
66,731.0000
59,178.5900
Diluted Average Shares
121,266.1200
121,266.1200
113,731.8730
66,731.0000
59,178.5900
Total Expenses
1,557.1630
2,990.1970
8,109.9920
25,006.1300
14,372.2290
Net Income from Continuing & Discontinued Operation
-3,584.2010
-3,780.9100
-9,243.0140
-25,118.2990
-14,325.1120
Normalized Income
-3,644.7023
-3,836.7176
-9,024.2504
-25,160.2243
-14,325.1120
Interest Income
6.1400
16.8120
29.8820
33.7300
116.9530
Interest Expense
2,582.9350
1,631.0050
1,096.0830
1,554.9410
69.8360
Net Interest Income
-2,576.7950
-1,614.1930
-1,066.2010
-1,521.2110
47.1170
EBIT
-985.0610
-2,080.3220
-8,110.5390
-23,524.8990
-14,255.2760
EBITDA
-972.1060
-2,066.6600
-8,104.2730
-23,512.2560
-14,240.4400
Reconciled Depreciation
12.9550
13.6620
6.2660
12.6430
14.8360
Net Income from Continuing Operation Net Minority Interest
-3,584.2010
-3,780.9100
-9,243.0140
-25,118.2990
-14,325.1120
Total Unusual Items Excluding Goodwill
71.1780
65.6560
-364.6060
56.8170
--
Total Unusual Items
71.1780
65.6560
-364.6060
56.8170
--
Normalized EBITDA
-1,043.2840
-2,132.3160
-7,739.6670
-23,569.0730
-14,240.4400
Tax Rate for Calcs
0.0002
0.0002
0.0004
0.0003
--
Tax Effect of Unusual Items
10.6767
9.8484
-145.8424
14.8917
--
3/31/2021 - 6/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CMRA Comera Life Sciences Holdings, Inc.
0.0002
0.00%
DOSE.CN Rapid Dose Therapeutics Corp.
0.2250
-6.25%
MSCL.TO Satellos Bioscience Inc.
0.8500
+1.19%
MBX.TO Microbix Biosystems Inc.
0.4200
+1.20%
CHGX.CN ChitogenX Inc.
0.0250
+66.67%
IKNA Ikena Oncology, Inc.
1.5600
-2.50%
LIXT Lixte Biotechnology Holdings, Inc.
2.5900
+12.61%
RVX.TO Resverlogix Corp.
0.0500
-9.09%
IBO.V Universal Ibogaine Inc.
0.0250
+25.00%
RPTX Repare Therapeutics Inc.
1.3800
+7.81%